|
CNOT7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.235800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.800400E-01 |
| Normal-vs-Stage2 |
7.738200E-01 |
| Normal-vs-Stage3 |
1.115430E-03 |
| Normal-vs-Stage4 |
5.396100E-03 |
| Stage1-vs-Stage2 |
9.412000E-01 |
| Stage1-vs-Stage3 |
2.121400E-03 |
| Stage1-vs-Stage4 |
1.470340E-02 |
| Stage2-vs-Stage3 |
8.604100E-02 |
| Stage2-vs-Stage4 |
1.344800E-01 |
| Stage3-vs-Stage4 |
7.862600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.514500E-02 |
| Normal-vs-AfricanAmerican |
7.57350000000212E-05 |
| Normal-vs-Asian |
7.930000E-02 |
| Caucasian-vs-AfricanAmerican |
1.783000E-03 |
| Caucasian-vs-Asian |
4.408600E-01 |
| AfricanAmerican-vs-Asian |
8.248200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.426200E-02 |
| Normal-vs-Female |
1.621410E-01 |
| Male-vs-Female |
5.095400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.730800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.890600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.399600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.750040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.313800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.913600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.527200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.051240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.212400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.164800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.370000E-01 |
| Normal-vs-Grade 2 |
9.592800E-01 |
| Normal-vs-Grade 3 |
1.402200E-03 |
| Normal-vs-Grade 4 |
9.54920000000303E-05 |
| Grade 1-vs-Grade 2 |
4.682800E-01 |
| Grade 1-vs-Grade 3 |
2.077900E-02 |
| Grade 1-vs-Grade 4 |
4.660300E-03 |
| Grade 2-vs-Grade 3 |
8.593300E-04 |
| Grade 2-vs-Grade 4 |
6.18230000000164E-05 |
| Grade 3-vs-Grade 4 |
7.004400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.005200E-01 |
| Normal-vs-ccB subtype |
9.763900E-03 |
| ccA subtype-vs-ccB subtype |
9.767500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.812100E-02 |
| Normal-vs-N1 |
3.967600E-01 |
| N0-vs-N1 |
7.797600E-01 |
|
|
